In vitro and in vivo delivery of antisense oligodeoxynucleotides using lipofection: application of antisense technique to growth suppression of experimental glioma.
Matsuno
A
A
Department of Neurosurgery, Teikyo University Ichihara Hospital, Chiba, Japan.
Nagashima
T
T
Katayama
H
H
Tamura
A
A
D000818:Animals; D001483:Base Sequence; D001932:Brain Neoplasms / Q000188:drug therapy / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects; D002467:Cell Nucleus / Q000378:metabolism / Q000473:pathology; D004337:Drug Carriers; D005910:Glioma / Q000188:drug therapy* / Q000473:pathology; D007202:Indicators and Reagents; D008081:Liposomes; D008869:Microtubule-Associated Proteins / Q000235:genetics*; D020319:Oligodeoxyribonucleotides, Antisense / Q000138:chemical synthesis / Q000493:pharmacokinetics / Q000494:pharmacology*; D010714:Phosphatidylethanolamines; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics; D016601:RNA-Binding Proteins / Q000235:genetics; D051381:Rats; D013873:Thionucleotides; D014407:Tumor Cells, Cultured
D004337:Drug Carriers; D007202:Indicators and Reagents; D008081:Liposomes; C490546:Map1a protein, rat; D008869:Microtubule-Associated Proteins; D020319:Oligodeoxyribonucleotides, Antisense; D010714:Phosphatidylethanolamines; D012333:RNA, Messenger; D016601:RNA-Binding Proteins; D013873:Thionucleotides; C020888:1,2-dielaidoylphosphatidylethanolamine